Email this article Bishofit in the treatment of rheumatoid arthritis
- Authors: Zborovsky АВ1, Martermyanov VF1, Sidorova EA1, Mozgovaya EE1, Zborovskaya IA1
-
Affiliations:
- Issue: Vol 78, No 5 (2003)
- Pages: 29-32
- Section: Editorial
- URL: https://ter-arkhiv.ru/0040-3660/article/view/29359
- ID: 29359
Cite item
Full Text
Abstract
Aim. To evaluate effectiveness of a natural mineral bishofit in combined treatment of rheumatoid arthritis (RA).
Material and methods. The study included 71 RA patients with minimal activity of the pathological process and articular disorders of stage II. Bishofit was used in baths and compresses. 33 AR patients of group 1 took bishofit baths (14 procedures) and non-steroid anti-inflammatory drugs (NSAID), 27 RA patients of group 2 were treated with bishofit compresses (14 procesures) and NSAID, 11 patients of group 3 (controls) received NSAID alone. The effect of the treatment was assessed on the basis of clinical data, the length of the affected joint circumference, antitryptic blood activity, activity ofmalate dehydrogenase, lactate dehydrogenase isoenzymes, plasmin, plasminogen, ESR, sialic acids. Results. Bishofit-treated patients showed earlier (by 5-6 days) and greater (by 25-35%) decrease of the pain, joint and inflammatory indices as well as duration of morning stiffness, length of the affected joint circumference and joint mobility, improvement of the tests' results. A response and an appreciable response to combined therapy with bishofit were achieved in 62.9-63.6% of cases vs 45.5% in the control group. Bishofit baths and compresses did not differ considerably by therapeutic efficacy.
Material and methods. The study included 71 RA patients with minimal activity of the pathological process and articular disorders of stage II. Bishofit was used in baths and compresses. 33 AR patients of group 1 took bishofit baths (14 procedures) and non-steroid anti-inflammatory drugs (NSAID), 27 RA patients of group 2 were treated with bishofit compresses (14 procesures) and NSAID, 11 patients of group 3 (controls) received NSAID alone. The effect of the treatment was assessed on the basis of clinical data, the length of the affected joint circumference, antitryptic blood activity, activity ofmalate dehydrogenase, lactate dehydrogenase isoenzymes, plasmin, plasminogen, ESR, sialic acids. Results. Bishofit-treated patients showed earlier (by 5-6 days) and greater (by 25-35%) decrease of the pain, joint and inflammatory indices as well as duration of morning stiffness, length of the affected joint circumference and joint mobility, improvement of the tests' results. A response and an appreciable response to combined therapy with bishofit were achieved in 62.9-63.6% of cases vs 45.5% in the control group. Bishofit baths and compresses did not differ considerably by therapeutic efficacy.
Keywords
References
- Зборовский А. Б., Цыбулина Е. В., Мартемьянов В. Ф., Сидорова Е. А. Бишофит в лечении больных деформирующим остеоартрозом. Клин. мед. 1991; 6: 92-94.
- Лиходеева В. А., Рыбак В. С., Смирнова Л. А. и др. Действие минерала бишофита на иммунную систему организма и генетический аппарат. В кн.: Сборник тезисов докладов 1-й Всероссийской конференции "Бишофит в лечении заболеваний суставов". Волгоград; 1993. 80.
- Островский О. В., Шипов А. А., Скороходова Е. Н. Изучение противовоспалительного действия бишофита на моделях отека лапки крысы. Там же. 9-10.
- Сидорова Е. А., Мартемьянов В. Ф., Ростовщикова Л. Н., Зборовский А. Б. Лечение бишофитом больных деформирующим остеоартрозом. В кн.: Фундаментальные исследования как основа создания лекарственных средств: Сборник тезисов 1-го Съезда Российского науч. о-ва фармакологов. Волгоград; 1995. 398.
- О разрешении применения бишофита в бальнеологической практике: (Приказ МЗ СССР № 306 от 18 марта 1985 г.). М; 1985.
- Еров Н. К. Объективные количественные показатели для определения степени активности и функциональной возможности суставов у больных ревматоидным артритом. Ревматология 1984; 4: 39-43.
Supplementary files
